Skip to content

Screening and clinical evaluation of novel biomarkers for diseases related to intestinal microbiota imbalance in the digestive system

Screening and clinical evaluation of novel biomarkers for diseases related to intestinal microbiota imbalance in the digestive system

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400088720
Enrollment
Unknown
Registered
2024-08-26
Start date
2024-08-30
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases related to intestinal microbiota imbalance

Interventions

Patients diagnosed with diseases related to intestinal imbalance of the digestive system:None

Sponsors

Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed with diseases related to intestinal imbalance of the digestive system, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), Clostridium difficile infectious enteritis (CDI), intestinal infectious diseases, radiation enteritis, Hp infection, biliary stones, etc., the specific diagnostic criteria are shown in the attached table. 2) The patient can understand the purpose and procedures of the study and agree to sign the informed consent form; 3) The patient is willing to complete the follow-up and various examinations as required.

Exclusion criteria

Exclusion criteria: 1) Patients with severe heart, lung, kidney, liver and other organ insufficiency; 2) Patients with a history of mental illness, cognitive impairment or other psychiatric disorders who are unable to cooperate with the study; 3) the patient has other diseases that are inconsistent with the study; 4) For medical and/or ethical reasons, the investigator considers it unsuitable to participate in the study.

Design outcomes

Primary

MeasureTime frame
Diagnostic accuracy of the disease;

Secondary

MeasureTime frame
Clinical remission rate;

Countries

China

Contacts

Public ContactJiazhi Liao

Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology

liaojiazhi@tjh.tjmu.edu.cn+86 153 0712 4188

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026